South Georgia and the South Sandwich Islands
Reimbursed Care Access
South Georgia & the South Sandwich Islands (SGSSI) is a British Overseas Territory with no comprehensive local healthcare/reimbursement system and a very small transient population; UK and locally-made ordinances govern law in the territory and, where local legislation is silent, English law and UK drug-control regimes are applied. Practically all classic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, ibogaine, ayahuasca, 2C‑X) are treated as strictly controlled (Schedule/Class I-equivalent) substances and have no authorised medical reimbursement or routine clinical access in SGSSI outside tightly regulated research or licenced import under the relevant Home Office/Commissioner permissions. Ketamine (and esketamine/Spravato) are medicines recognised in UK regulatory frameworks but there is no local NHS‑style prescribing or reimbursement infrastructure in SGSSI; any use would be limited to authorised medical practice or emergency care under the Commissioner’s healthcare arrangements and subject to UK controls. (Legal framework: Commissioner-made Ordinances; where territory law is silent, English law is applied as far as circumstances permit.) [https://laws.gov.gs/1985-onwards-laws-of-sgssi/|SGSSI Laws - 1985 onwards] [https://www.gov.uk/government/publications/circular-0012024-control-of-20-new-drugs/0012024-the-misuse-of-drugs-act-1971-amendment-order-2024-and-the-misuse-of-drugs-and-misuse-of-drugs-designation-england-and-wales-and-scotlan|UK: Misuse of Drugs Act / Scheduling guidance].
No clinical trials found for this country yet.